Skip to main
RDNT

RadNet (RDNT) Stock Forecast & Price Target

RadNet (RDNT) Analyst Ratings

Based on 5 analyst ratings
Strong Buy
Strong Buy 80%
Buy 20%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

RadNet Inc's positive outlook is bolstered by ongoing technology investments that are expected to improve operational leverage and productivity in a challenging labor environment. The company's joint venture strategy serves as a key differentiator, facilitating ongoing volume growth, enhanced market penetration, and increased contracting leverage. Additionally, strong demand trends combined with persistent patient backlogs have driven significant growth in advanced procedure categories, which now account for 27.5% of volumes, reinforcing margin benefits as the service mix continues to evolve.

Bears say

RadNet Inc faces significant risks that contribute to a negative outlook, particularly regarding potential reimbursement pressures and labor challenges, which could adversely impact financial performance. Additionally, the company is struggling to achieve profitability within its Digital Health segment, specifically in its AI initiatives, further complicating its overall financial stability. Despite some operational improvements with the TechLive rollout, including a notable reduction in MRI room closures, the underlying financial pressures may outweigh the benefits of such advancements.

RadNet (RDNT) has been analyzed by 5 analysts, with a consensus rating of Strong Buy. 80% of analysts recommend a Strong Buy, 20% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of RadNet and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About RadNet (RDNT) Forecast

Analysts have given RadNet (RDNT) a Strong Buy based on their latest research and market trends.

According to 5 analysts, RadNet (RDNT) has a Strong Buy consensus rating as of Jan 1, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $83.60, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $83.60, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

RadNet (RDNT)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.